+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030 - Product Thumbnail Image

Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

  • Report
  • November 2022
  • 100 Pages
  • Global
From
Global Bipolar Disorder Therapeutics Market Outlook 2028 - Product Thumbnail Image

Global Bipolar Disorder Therapeutics Market Outlook 2028

  • Report
  • August 2020
  • Global
From
Antidepressant Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Antidepressant Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
Psychedelic Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Psychedelic Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Postpartum Depression Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Postpartum Depression Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Treatment- Resistant Depression Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Treatment- Resistant Depression Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Major Depressive Disorder - Epidemiology Forecast - 2032 - Product Thumbnail Image

Major Depressive Disorder - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 148 Pages
  • Global
From
Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028 - Product Thumbnail Image

Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028

  • Report
  • February 2020
  • 253 Pages
  • Global
From
Benzodiazepine Drugs Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Benzodiazepine Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • June 2020
  • 112 Pages
  • Global
From
Global Antidepressants Market - Segmented by Antidepressants therapies, Depressive Disorders, and Geography - Growth, Trends and Forecasts (2018 - 2023) - Product Thumbnail Image

Global Antidepressants Market - Segmented by Antidepressants therapies, Depressive Disorders, and Geography - Growth, Trends and Forecasts (2018 - 2023)

  • Report
  • February 2018
  • 105 Pages
  • Global
From
Treatment-Resistant Depression (TRD) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Treatment-Resistant Depression (TRD) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 165 Pages
  • Global
From
Treatment-resistant Depression - Epidemiology Forecast - 2032 - Product Thumbnail Image

Treatment-resistant Depression - Epidemiology Forecast - 2032

  • Report
  • April 2023
  • 82 Pages
  • Global
From
United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Japan, United States Japan, United States
From
CAPLYTA (Lumateperone) Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CAPLYTA (Lumateperone) Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SPRAVATO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SPRAVATO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more